The IABC is now accepting papers for the 8th international
conference in Nanking, China. The bioelectromagnetics group in
Copenhagen is presenting 3 papers, and for non-english speaking
participants, we are once again offering to help in preparation of
your manuscript, should it be neccessary. (Half of the last congress
proceedings were written by Chinese, and I can tell you, it is
difficult reading! Not to mention the Hungarians, Germans, Greeks,
etc...)

Scott Hill
the bioelectromagnetics group
Copenhagen, Denmark
bioelectromagnetics@...
webmaster@...
frontiersciences@...

Announcing
The Eighth International Congress of the IABC
International Association for
Biologically Closed Electric Circuits in Biomedicine

Dates: September 20 –24th, 2004

Venue: Guangxi University of Medical Sciences, Nan-
Ning
Guangxi Province, China

Sponsorship: The IABC in cooperation with the
China-Japan Friendship Hospital (CJFH) and
The Ministry of Health, China

Local Organizer: Guangxi University of Medical Sciences

Honorary Presidents: Professor Bjorn E. W. Nordenstrom, M.D.,
Ph.D.
Professor XIN Yu-Ling, M.D.
Dr. HE Hui-Yu, President, CJFH

Advisory Board: Chairman, Professor Jerker Olsson, IABC President;
Sweden
Members: Professor George D. O'Clock, IABC President
Emeritus, (USA)
Professor Jorgen Nordenstrom, IABC Vice
President, (Sweden)
Professor Friedrich R. Douwes, (Germany)
Dr. Finn Scott Anderson, (Denmark)
Professor Photios Anninos, (Greece)
Professor LIU Gan-Zhong, (China)
Professor CHEN Ming-Feng (Taipei, China)

Congress President: Professor TANG Bu-Jian
(President, Guangxi University of
Medical Science
Vice President: Mr. Carl Firley (IABC Vice President
and Secretary General)
Co-Secretaries General: Dr. LI Li and Dr. ZHANG Wei, CJFH

Principal Topics of the Congress:
New advances in the theoretical research of Biologically Closed
Electric Circuits
Basic Research on the application of EchT (electrochemical therapy)
to malignant tumors.
3. Clinical effectiveness of EchT applied to malignant tumors;
5. Clinical effectiveness of EchT applied to benign tumors;
6. New advances in treatment of tumors with thermotherapy;
7. Treatment of tumors with integrative (or alternative)
medicine;
8. Treatment of neurological disorders with pico Tesla magnetic
therapy, (pTMT);
9. Others

http://www.iabc.readywebsites.com/
First Call for Papers

Eighth International Congress of the IABC
http://www.iabc.readywebsites.com/

Requirements for Submitting Papers:

1. Please submit the full text of the paper preceded by an abstract
limited to no more
than 500 words.

2. Format: Papers should include; Object, Method, Results, and
Conclusion

3. Please include with your submission the following information::
Name(s) of author(s)
Institution
Postal Address and code
Phone and/or Fax Numbers
E-mail address

4. Deadline for Submitting Papers: May 31, 2004

5. Persons outside mainland China: Please submit papers using MS
WORD, and e-mail to iabc@... or send
soft disc to:
Mr. Carl F. Firley
4976 SW Bimini Circle S.
Palm City, Florida, 34997 USA

______________________Abstract Submission
Form___________________________

Name:__________________________________
Title__________________________

Title of Paper ______________________________ Institution
_____________________

Post Address: ______________________________________________________

Phone/Fax numbers: ________________________ email address:
__________________

*********************************************************************
For Additional Information Please Contact one of the following
persons:
Mr. Carl Firley, Phone +772 283 2180; Fax: 772 283 9943; e-mail
iabc@...
Professor XIN Yu-Ling; +86-10-64227670; suime@...
Dr. ZHANG Wei; +86-10-64221122 ext. 4527; e-mail:
drzhangwei@...
Scott Hill, the bioelectromagnetics group, Copenhagen +45 25751467
Scott@...
bioelectromagnetics@...
*********************************************************************


Dear IABC Members, Associates, and Supporters,

Attached please find:

1. Announcement: 8th International Congress of the IABC
to be held in Nanning, China,
September 20 - 24th, 2004

2. First Call for Papers. Deadline is May 31, 2004.
Information needed to prepare submissions is included
in the attachments.

You will be pleased to learn that the scope of research involving
BCEC theory has expanded, and remarkable new medical successes are
being realized. Additional information is included in the
attachment.

IABC Vice President, Professor Xin Yu-Ling, has been working
tirelessly for the past decade to help physicians and hospitals in
the Pacific Rim develop the capacity to offer electrochemical
therapy (EchT) to cancer and hemangioma patients. Today South Korea
and Taiwan, China, and Indonesia are offering this exceptionally
successful therapy.

In Greece, Professor P. Anninos and colleagues have been
successfully treating neurological disorders using picoTesla
Magnetic Therapy, or pTMT. In fact, his recent paper on Alzheimer's
Disease will, according to the publisher, be the first paper ever
accepted for publication demonstrating a therapy which will reverse
the symptoms of this devastating disease. The galley proofs are
being reviewed at this writing.

In the U.S. Professor George D. O'Clock and Dr. John Jarding, are
making steady progress with FDA required research leading to
eventual approval of the application of microcurrents to treat Age
Related Macular Degeneration.

Finally, EchT is being researched by a group at the University of
Pennsylvania. Let's hope that someday this therapy will become as
accepted and widely available in the US as it is in China, Germany,
Poland, and other countries of the world.

Information on the venue may be accessed by means of "Google" ...
type in "Nanning, China" and this should do it. Nanning is one of
the most beautiful cities in China, and autumn is the best time of
year for a visit.

If you are unable to open the attachment, please advise. The
information will be sent by other means.

Cordially,

Carl F. Firley
IABC Vice President and Secretary General
4976 SW Bimini Circle S.
Palm City, Florida, 34990
USA

Phone: +772 283 2180
Fax: +772 285 9943